TLR9 and lung carcinoma: For example, in murine models of lung cancer, direct inhalation of immunostimulatory CpG-ODN motifs, which activate Toll-like Receptor 9 (TLR9) signaling, stimulated anti-cancer activity by modifying the tumor microenvironment in favour of increased recruitment and activation of T cells (14).